Uploaded December 2025 | Updated November 2026, 16 hours ago
Presented By: Rongrong Huang, PhD, DABCC
Speaker Biography: Dr. Rongrong Huang is a board-certified clinical chemist (DABCC) and an Assistant Professor of Pathology & Immunology at Baylor College of Medicine. She currently serves as the Director of Clinical Chemistry, Diagnostic Immunology, Point-of-Care Testing, and Laboratory Quality at Harris Health Ben Taub Hospital. Dr. Huang is actively engaged in the field of clinical chemistry and laboratory medicine, delivering oral and poster presentations at national and international scientific conferences, publishing peer-reviewed articles, and contributing to professional societies such as CLSI Document Development committees. She was named as one of the American Society for Clinical Pathology (ASCP) 40 Under Forty honoree in 2021. Before her directorship, Dr. Huang gained extensive experience in developing and validating mass spectrometry-based tests for various clinical applications. Her current clinical research interests include the application of new technologies for advanced clinical diagnosis and enhanced patient care, data science for quality improvement and test utilization, and biomarkers of cardiovascular disease.
Webinar: HbA1c Testing in Practice: Challenges and Opportunities in Point-of-Care and Laboratory Settings
Webinar Abstract: Accurate diagnosis and effective management of diabetes are essential for optimizing patient outcomes and preventing complications. Hemoglobin A1c (HbA1c) testing plays a central role in assessing and monitoring glycemic control. However, selecting the appropriate testing method and interpreting results can be complex. This requires an understanding of the clinical significance of HbA1c in various patient care settings, as well as a deep knowledge of not only the advantages and limitations of different methodologies, but also the analytical and clinical impact of hemoglobin variants. While laboratory-based HbA1c testing is considered the gold standard for establishing diagnosis of diabetes, point-of-care (POC) HbA1c testing offers distinct advantages in outpatient settings due to its rapid turnaround time, making it valuable for both diabetes screening and treatment management.
This presentation will review the limitations of several major methodologies commonly used for HbA1c measurement. Using real-life case studies, it will explore the challenges to accurate HbA1c assessment, and the discrepancies observed across different methods, which may arise from analytical or pathophysiological factors—or both. The clinical utility of laboratory-based versus POC HbA1c testing will be compared, highlighting the role of reflex algorithms, automated processes, and data analytics in enhancing testing accuracy and efficiency.
Learning Objectives:
1. Describe various HbA1c measurement methods used in central laboratories and point-of-care (POC) settings
2. Identify analytical and clinical limitations of HbA1c measurement related to method type and hemoglobin variants
3. Compare the clinical utility of laboratory-based versus point-of-care HbA1c testing
Earn PACE Credits: 1. Make sure you’re a registered member of Labroots (labroots.com/virtual-event/clinical-diagnostics-research-2025/agenda) 2. Watch the webinar on YouTube or on the Labroots Website (labroots.com/virtual-event/clinical-diagnostics-research-2025/agenda) 3. Click Here to get your PACE credits (Expiration date –11/12/2026): (labroots.com/virtual-event/clinical-diagnostics-research-2025/continuing-education-credits) This link will be located in the CMS in the webinar CE tab – please enable third party PACE link
Labroots on Social:
Facebook: facebook.com/LabRootsInc
Twitter: twitter.com/LabRoots
LinkedIn: linkedin.com/company/labroots
Instagram: instagram.com/labrootsinc
Pinterest: pinterest.com/labroots
SnapChat: labroots_inc
Presented By: Rongrong Huang, PhD, DABCC
Speaker Biography: Dr. Rongrong Huang is a board-certified clinical chemist (DABCC) and an Assistant Professor of Pathology & Immunology at Baylor College of Medicine. She currently serves as the Director of Clinical Chemistry, Diagnostic Immunology, Point-of-Care Testing, and Laboratory Quality at Harris Health Ben Taub Hospital. Dr. Huang is actively engaged in the field of clinical chemistry and laboratory medicine, delivering oral and poster presentations at national and international scientific conferences, publishing peer-reviewed articles, and contributing to professional societies such as CLSI Document Development committees. She was named as one of the American Society for Clinical Pathology (ASCP) 40 Under Forty honoree in 2021. Before her directorship, Dr. Huang gained extensive experience in developing and validating mass spectrometry-based tests for various clinical applications. Her current clinical research interests include the application of new technologies for advanced clinical diagnosis and enhanced patient care, data science for quality improvement and test utilization, and biomarkers of cardiovascular disease.
Webinar: HbA1c Testing in Practice: Challenges and Opportunities in Point-of-Care and Laboratory Settings
Webinar Abstract: Accurate diagnosis and effective management of diabetes are essential for optimizing patient outcomes and preventing complications. Hemoglobin A1c (HbA1c) testing plays a central role in assessing and monitoring glycemic control. However, selecting the appropriate testing method and interpreting results can be complex. This requires an understanding of the clinical significance of HbA1c in various patient care settings, as well as a deep knowledge of not only the advantages and limitations of different methodologies, but also the analytical and clinical impact of hemoglobin variants. While laboratory-based HbA1c testing is considered the gold standard for establishing diagnosis of diabetes, point-of-care (POC) HbA1c testing offers distinct advantages in outpatient settings due to its rapid turnaround time, making it valuable for both diabetes screening and treatment management.
This presentation will review the limitations of several major methodologies commonly used for HbA1c measurement. Using real-life case studies, it will explore the challenges to accurate HbA1c assessment, and the discrepancies observed across different methods, which may arise from analytical or pathophysiological factors—or both. The clinical utility of laboratory-based versus POC HbA1c testing will be compared, highlighting the role of reflex algorithms, automated processes, and data analytics in enhancing testing accuracy and efficiency.
Learning Objectives:
1. Describe various HbA1c measurement methods used in central laboratories and point-of-care (POC) settings
2. Identify analytical and clinical limitations of HbA1c measurement related to method type and hemoglobin variants
3. Compare the clinical utility of laboratory-based versus point-of-care HbA1c testing
Earn PACE Credits: 1. Make sure you’re a registered member of Labroots (labroots.com/virtual-event/clinical-diagnostics-research-2025/agenda) 2. Watch the webinar on YouTube or on the Labroots Website (labroots.com/virtual-event/clinical-diagnostics-research-2025/agenda) 3. Click Here to get your PACE credits (Expiration date –11/12/2026): (labroots.com/virtual-event/clinical-diagnostics-research-2025/continuing-education-credits) This link will be located in the CMS in the webinar CE tab – please enable third party PACE link
Labroots on Social:
Facebook: facebook.com/LabRootsInc
Twitter: twitter.com/LabRoots
LinkedIn: linkedin.com/company/labroots
Instagram: instagram.com/labrootsinc
Pinterest: pinterest.com/labroots
SnapChat: labroots_inc










